[
  {
    "ts": "2025-12-10T14:09:21+00:00",
    "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More",
    "summary": "Pre-Market Stock Futures: Futures are trading modestly lower as the big day has finally arrived: the Federal Reserve will wrap up its last meeting of 2025, and the odds still heavily favor a 25-basis-point rate hike. The worry hanging over traders is that many fear a “hawkish rate cut.” Where they do cut 25 basis ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More",
    "url": "https://247wallst.com/investing/2025/12/10/here-are-wednesdays-top-wall-street-analyst-research-calls-abbvie-amazon-com-biogen-echostar-ferrari-ge-vernova-pepsico-take-two-interactive-and-more/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f061aa8a-a13b-3b17-beb0-1784aef9ebd4",
      "content": {
        "id": "f061aa8a-a13b-3b17-beb0-1784aef9ebd4",
        "contentType": "STORY",
        "title": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More",
        "description": "",
        "summary": "Pre-Market Stock Futures: Futures are trading modestly lower as the big day has finally arrived: the Federal Reserve will wrap up its last meeting of 2025, and the odds still heavily favor a 25-basis-point rate hike. The worry hanging over traders is that many fear a “hawkish rate cut.” Where they do cut 25 basis ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More",
        "pubDate": "2025-12-10T14:09:21Z",
        "displayTime": "2025-12-10T14:09:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/74bc60924e76f984dbb62a4d8faf6ff8",
          "originalWidth": 1366,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/28SlD17sAW4WuYCLqrNyeg--~B/aD03Njg7dz0xMzY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/74bc60924e76f984dbb62a4d8faf6ff8.cf.webp",
              "width": 1366,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_WgxvwyvOnfgA_auAxWYuw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/74bc60924e76f984dbb62a4d8faf6ff8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/12/10/here-are-wednesdays-top-wall-street-analyst-research-calls-abbvie-amazon-com-biogen-echostar-ferrari-ge-vernova-pepsico-take-two-interactive-and-more/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wednesday-top-wall-street-analyst-140921827.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "CLH"
            },
            {
              "symbol": "HP"
            },
            {
              "symbol": "NE"
            },
            {
              "symbol": "CMC"
            },
            {
              "symbol": "OWL"
            },
            {
              "symbol": "VLTO"
            },
            {
              "symbol": "LECO"
            },
            {
              "symbol": "BIRK"
            },
            {
              "symbol": "RBLX"
            },
            {
              "symbol": "SN"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "SATS"
            },
            {
              "symbol": "RACE"
            },
            {
              "symbol": "GEV"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "TTWO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T14:00:00+00:00",
    "headline": "Great Point Partners Acquires a Majority Stake in Lenis Group, a Full-Service Specialty Pharmaceutical Commercialization and Distribution Partner",
    "summary": "GREENWICH, Conn. & LJUBLJANA, Slovenia, December 10, 2025--Great Point Partners (\"GPP\" or \"the Firm\"), a Greenwich-based private investment firm focused exclusively on the healthcare industry, today announced that it has acquired a majority stake in Lenis Group (\"Lenis\" or \"the Company\"), a fast-growing Slovenian-based full-service regional commercialization and distribution partner for niche and specialty Rx medicines in Central and Eastern Europe (\"CEE\").",
    "url": "https://finance.yahoo.com/news/great-point-partners-acquires-majority-140000641.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "966729d9-6155-3f45-a475-b207af2f7c08",
      "content": {
        "id": "966729d9-6155-3f45-a475-b207af2f7c08",
        "contentType": "STORY",
        "title": "Great Point Partners Acquires a Majority Stake in Lenis Group, a Full-Service Specialty Pharmaceutical Commercialization and Distribution Partner",
        "description": "",
        "summary": "GREENWICH, Conn. & LJUBLJANA, Slovenia, December 10, 2025--Great Point Partners (\"GPP\" or \"the Firm\"), a Greenwich-based private investment firm focused exclusively on the healthcare industry, today announced that it has acquired a majority stake in Lenis Group (\"Lenis\" or \"the Company\"), a fast-growing Slovenian-based full-service regional commercialization and distribution partner for niche and specialty Rx medicines in Central and Eastern Europe (\"CEE\").",
        "pubDate": "2025-12-10T14:00:00Z",
        "displayTime": "2025-12-10T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/7b38c7343830ccf0335c958b574ef1f6",
          "originalWidth": 1000,
          "originalHeight": 254,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ERAW1S8vWWenO.VjDgTLpg--~B/aD0yNTQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7b38c7343830ccf0335c958b574ef1f6.cf.webp",
              "width": 1000,
              "height": 254,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QgFBm1sqTn1Qh.MkijSfew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/7b38c7343830ccf0335c958b574ef1f6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/great-point-partners-acquires-majority-140000641.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/great-point-partners-acquires-majority-140000641.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T13:36:58+00:00",
    "headline": "HSBC highlights one pharma stock to buy and one to sell for 2026",
    "summary": "Investing.com -- HSBC shifted its ratings across U.S. large-cap pharmaceuticals in a note on Wednesday, led by Rajesh Kumar, upgrading AbbVie to Buy while cutting Biogen to Reduce, as the bank refreshed its 2026 sector outlook.",
    "url": "https://finance.yahoo.com/news/hsbc-highlights-one-pharma-stock-133658900.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "42a5075e-dab5-340c-b7c0-8e1863db579d",
      "content": {
        "id": "42a5075e-dab5-340c-b7c0-8e1863db579d",
        "contentType": "STORY",
        "title": "HSBC highlights one pharma stock to buy and one to sell for 2026",
        "description": "",
        "summary": "Investing.com -- HSBC shifted its ratings across U.S. large-cap pharmaceuticals in a note on Wednesday, led by Rajesh Kumar, upgrading AbbVie to Buy while cutting Biogen to Reduce, as the bank refreshed its 2026 sector outlook.",
        "pubDate": "2025-12-10T13:36:58Z",
        "displayTime": "2025-12-10T13:36:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hsbc-highlights-one-pharma-stock-133658900.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hsbc-highlights-one-pharma-stock-133658900.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HSBC"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T14:40:00+00:00",
    "headline": "Amazon initiated, GE Vernova upgraded: Wall Street's top analyst calls",
    "summary": "Amazon initiated, GE Vernova upgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/amazon-initiated-ge-vernova-upgraded-144000835.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "dfe24d9e-4293-38d5-8bec-b4b55d9cd6bd",
      "content": {
        "id": "dfe24d9e-4293-38d5-8bec-b4b55d9cd6bd",
        "contentType": "STORY",
        "title": "Amazon initiated, GE Vernova upgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "Amazon initiated, GE Vernova upgraded: Wall Street's top analyst calls",
        "pubDate": "2025-12-10T14:40:00Z",
        "displayTime": "2025-12-10T14:40:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amazon-initiated-ge-vernova-upgraded-144000835.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amazon-initiated-ge-vernova-upgraded-144000835.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GEV"
            },
            {
              "symbol": "UAA"
            },
            {
              "symbol": "RBLX"
            },
            {
              "symbol": "SN"
            },
            {
              "symbol": "EMR"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "DYN"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "IOT"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "TEX"
            },
            {
              "symbol": "NE"
            },
            {
              "symbol": "RRX"
            },
            {
              "symbol": "VLTO"
            },
            {
              "symbol": "NKE"
            },
            {
              "symbol": "CPRI"
            },
            {
              "symbol": "TJX"
            },
            {
              "symbol": "PVH"
            },
            {
              "symbol": "BIRK"
            },
            {
              "symbol": "UA"
            },
            {
              "symbol": "ONON"
            },
            {
              "symbol": "PLNT"
            },
            {
              "symbol": "M"
            },
            {
              "symbol": "LULU"
            },
            {
              "symbol": "DECK"
            },
            {
              "symbol": "TPR"
            },
            {
              "symbol": "RL"
            },
            {
              "symbol": "GAP"
            },
            {
              "symbol": "VFC"
            },
            {
              "symbol": "URBN"
            },
            {
              "symbol": "VSCO"
            },
            {
              "symbol": "BBWI"
            },
            {
              "symbol": "PTON"
            },
            {
              "symbol": "BURL"
            },
            {
              "symbol": "TTWO"
            },
            {
              "symbol": "ROST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T17:40:42+00:00",
    "headline": "ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL",
    "summary": "AbbVie and Genmab’s Epkinly triplet is poised to become a new standard of care for FL.",
    "url": "https://www.clinicaltrialsarena.com/analyst-comment/ash-2025-abbvie-genmab-epkinly-new-standard-second-line-fl/",
    "source": "Clinical Trials Arena",
    "provider": "yfinance",
    "raw": {
      "id": "9e96060a-811d-3c65-9d5c-a1c762d5e732",
      "content": {
        "id": "9e96060a-811d-3c65-9d5c-a1c762d5e732",
        "contentType": "STORY",
        "title": "ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL",
        "description": "",
        "summary": "AbbVie and Genmab’s Epkinly triplet is poised to become a new standard of care for FL.",
        "pubDate": "2025-12-10T17:40:42Z",
        "displayTime": "2025-12-10T17:40:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/clinical_trials_arena_396/8b0328984aaf15987e0ef88bd660bb78",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "FL is the most common indolent form of B-cell NHL. Credit: Motortion Films/Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k3h1WJrDD4SxaUToItmWyg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/8b0328984aaf15987e0ef88bd660bb78.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t1rigubQYBFYjTu2L5DoWg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/clinical_trials_arena_396/8b0328984aaf15987e0ef88bd660bb78.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Clinical Trials Arena",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.clinicaltrialsarena.com/analyst-comment/ash-2025-abbvie-genmab-epkinly-new-standard-second-line-fl/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ash-2025-abbvie-genmab-epkinly-174042457.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "GMAB"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T16:13:39+00:00",
    "headline": "Fed Cuts Rates for Third Time This Year, Signals One More in 2026",
    "summary": "The S&P 500 Index ($SPX ) (SPY ) today is down up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.01%. In a divided vote, the Federal Reserve approved a third 25-basis-point...",
    "url": "https://www.barchart.com/story/news/36554236/stock-investors-are-cautious-ahead-of-fomc-results-and-powell-comments",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "bb501d7d-a259-384c-8562-77601995cc38",
      "content": {
        "id": "bb501d7d-a259-384c-8562-77601995cc38",
        "contentType": "STORY",
        "title": "Fed Cuts Rates for Third Time This Year, Signals One More in 2026",
        "description": "",
        "summary": "The S&P 500 Index ($SPX ) (SPY ) today is down up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.01%. In a divided vote, the Federal Reserve approved a third 25-basis-point...",
        "pubDate": "2025-12-10T16:13:39Z",
        "displayTime": "2025-12-10T16:13:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/eaf2c839d1e4d32f136359aad54e681a",
          "originalWidth": 1600,
          "originalHeight": 1067,
          "caption": "Federal Reserve Building by pabradyphoto via iStock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pFtk_8H0k_mEcI4q1Sagog--~B/aD0xMDY3O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/barchart_com_477/eaf2c839d1e4d32f136359aad54e681a.cf.webp",
              "width": 1600,
              "height": 1067,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JhXC8usjf6C3T13UaJI6nA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/eaf2c839d1e4d32f136359aad54e681a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/36554236/stock-investors-are-cautious-ahead-of-fomc-results-and-powell-comments",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fed-cuts-rates-third-time-161339330.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^NDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]